| 0 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
404 |
0.0842 |
| 1 |
Cholinesterase Inhibitor [EPC] |
428 |
0.0288 |
| 2 |
Typical Antipsychotic [EPC] |
484 |
0.0245 |
| 3 |
Dopamine-2 Receptor Antagonist [EPC] |
131 |
0.0241 |
| 4 |
Melanocortin 4 Receptor Agonist [EPC] |
1 |
0.0233 |
| 5 |
Neuraminidase Inhibitor [EPC] |
58 |
0.0224 |
| 6 |
Partial Opioid Agonist/Antagonist [EPC] |
1 |
0.0208 |
| 7 |
Catechol-O-Methyltransferase Inhibitor [EPC] |
233 |
0.0204 |
| 8 |
Atypical Antipsychotic [EPC] |
6084 |
0.0144 |
| 9 |
Anti-epileptic Agent [EPC] |
2621 |
0.0137 |
| 10 |
Mood Stabilizer [EPC] |
2439 |
0.0137 |
| 11 |
Vesicular Monoamine Transporter 2 Inhibitor [EPC] |
94 |
0.0135 |
| 12 |
Monobactam Antibacterial [EPC] |
28 |
0.0133 |
| 13 |
Central alpha-2 Adrenergic Agonist [EPC] |
617 |
0.0132 |
| 14 |
Leukotriene Receptor Antagonist [EPC] |
224 |
0.0126 |
| 15 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
538 |
0.0120 |
| 16 |
Central Nervous System Stimulant [EPC] |
742 |
0.0114 |
| 17 |
Aromatic Amino Acid [EPC] |
575 |
0.0113 |
| 18 |
Influenza A M2 Protein Inhibitor [EPC] |
124 |
0.0100 |
| 19 |
Tricyclic Antidepressant [EPC] |
4 |
0.0098 |
| 20 |
Benzodiazepine [EPC] |
5367 |
0.0091 |
| 21 |
Monoamine Oxidase Inhibitor [EPC] |
23 |
0.0088 |
| 22 |
Aldehyde Dehydrogenase Inhibitor [EPC] |
7 |
0.0085 |
| 23 |
Tubulin Inhibiting Agent [EPC] |
2 |
0.0083 |
| 24 |
Benzodiazepine Antagonist [EPC] |
5 |
0.0079 |
| 25 |
Nonergot Dopamine Agonist [EPC] |
172 |
0.0077 |
| 26 |
Sigma-1 Agonist [EPC] |
48 |
0.0074 |
| 27 |
Carnitine Analog [EPC] |
17 |
0.0073 |
| 28 |
Ergot Derivative [EPC] |
27 |
0.0071 |
| 29 |
Serotonin Reuptake Inhibitor [EPC] |
494 |
0.0071 |
| 30 |
gamma-Aminobutyric Acid A Receptor Agonist [EPC] |
9 |
0.0070 |
| 31 |
Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
295 |
0.0067 |
| 32 |
Cannabinoid [EPC] |
50 |
0.0064 |
| 33 |
Histamine-1 Receptor Antagonist [EPC] |
218 |
0.0060 |
| 34 |
Amyloid Beta-directed Antibody [EPC] |
2 |
0.0054 |
| 35 |
Glucosylceramide Synthase Inhibitor [EPC] |
10 |
0.0053 |
| 36 |
Androgen [EPC] |
207 |
0.0051 |
| 37 |
Methylating Agent [EPC] |
4 |
0.0049 |
| 38 |
Muscle Relaxant [EPC] |
178 |
0.0047 |
| 39 |
Recombinant Human Growth Hormone [EPC] |
60 |
0.0046 |
| 40 |
Sympathomimetic-like Agent [EPC] |
128 |
0.0045 |
| 41 |
Glycolipid Disialoganglioside-directed Antibody [EPC] |
3 |
0.0044 |
| 42 |
Benzothiazole [EPC] |
7 |
0.0043 |
| 43 |
Antidote [EPC] |
40 |
0.0043 |
| 44 |
Non-Standardized Plant Allergenic Extract [EPC] |
39 |
0.0040 |
| 45 |
Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] |
1 |
0.0040 |
| 46 |
Vitamin B6 Analog [EPC] |
1 |
0.0039 |
| 47 |
General Anesthetic [EPC] |
127 |
0.0039 |
| 48 |
Standardized Chemical Allergen [EPC] |
49 |
0.0038 |
| 49 |
5-alpha Reductase Inhibitor [EPC] |
220 |
0.0037 |
| 50 |
Osmotic Laxative [EPC] |
647 |
0.0037 |
| 51 |
Antimalarial [EPC] |
25 |
0.0036 |
| 52 |
5-Lipoxygenase Inhibitor [EPC] |
2 |
0.0036 |
| 53 |
Penem Antibacterial [EPC] |
5 |
0.0036 |
| 54 |
Opioid Agonist [EPC] |
833 |
0.0035 |
| 55 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
47 |
0.0035 |
| 56 |
Melatonin Receptor Agonist [EPC] |
38 |
0.0034 |
| 57 |
Interferon alpha [EPC] |
191 |
0.0034 |
| 58 |
Leptin Analog [EPC] |
3 |
0.0033 |
| 59 |
Non-Standardized Insect Allergenic Extract [EPC] |
13 |
0.0033 |
| 60 |
Macrolide Antimicrobial [EPC] |
135 |
0.0033 |
| 61 |
Stimulant Laxative [EPC] |
35 |
0.0032 |
| 62 |
Recombinant Human Deoxyribonuclease 1 [EPC] |
54 |
0.0032 |
| 63 |
Cephalosporin Antibacterial [EPC] |
21 |
0.0031 |
| 64 |
Antihypoglycemic Agent [EPC] |
9 |
0.0031 |
| 65 |
Anthelmintic [EPC] |
7 |
0.0031 |
| 66 |
Osmotic Diuretic [EPC] |
12 |
0.0030 |
| 67 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
360 |
0.0030 |
| 68 |
Orexin Receptor Antagonist [EPC] |
39 |
0.0030 |
| 69 |
Antiprotozoal [EPC] |
26 |
0.0029 |
| 70 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
208 |
0.0029 |
| 71 |
Anticholinergic [EPC] |
35 |
0.0028 |
| 72 |
Vitamin A [EPC] |
141 |
0.0028 |
| 73 |
Nucleoside Analog Antiviral [EPC] |
220 |
0.0028 |
| 74 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
39 |
0.0028 |
| 75 |
HMG-CoA Reductase Inhibitor [EPC] |
957 |
0.0027 |
| 76 |
Standardized Insect Venom Allergenic Extract [EPC] |
14 |
0.0027 |
| 77 |
Barbiturate [EPC] |
27 |
0.0026 |
| 78 |
Cholinergic Nicotinic Agonist [EPC] |
143 |
0.0026 |
| 79 |
Carbonic Anhydrase Inhibitor [EPC] |
42 |
0.0026 |
| 80 |
Nicotinic Acid [EPC] |
158 |
0.0026 |
| 81 |
l-Thyroxine [EPC] |
369 |
0.0026 |
| 82 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
94 |
0.0025 |
| 83 |
Non-Standardized Fungal Allergenic Extract [EPC] |
8 |
0.0025 |
| 84 |
Non-Standardized Chemical Allergen [EPC] |
22 |
0.0025 |
| 85 |
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] |
2 |
0.0024 |
| 86 |
Methylxanthine [EPC] |
100 |
0.0024 |
| 87 |
Nitrate Vasodilator [EPC] |
185 |
0.0024 |
| 88 |
Proton Pump Inhibitor [EPC] |
1087 |
0.0023 |
| 89 |
Adrenocorticotropic Hormone [EPC] |
2 |
0.0023 |
| 90 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
152 |
0.0023 |
| 91 |
Antifibrinolytic Agent [EPC] |
16 |
0.0022 |
| 92 |
Partial Opioid Agonist [EPC] |
175 |
0.0022 |
| 93 |
Plasma Volume Expander [EPC] |
5 |
0.0022 |
| 94 |
Pyrethroid [EPC] |
3 |
0.0022 |
| 95 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
2087 |
0.0022 |
| 96 |
Cardiac Glycoside [EPC] |
138 |
0.0021 |
| 97 |
Non-Standardized Food Allergenic Extract [EPC] |
29 |
0.0021 |
| 98 |
Expectorant [EPC] |
323 |
0.0021 |
| 99 |
beta Lactamase Inhibitor [EPC] |
8 |
0.0021 |
| 100 |
Cholinergic Muscarinic Antagonist [EPC] |
66 |
0.0021 |
| 101 |
Oxazolidinone Antibacterial [EPC] |
44 |
0.0021 |
| 102 |
Platelet Aggregation Inhibitor [EPC] |
1026 |
0.0020 |
| 103 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
136 |
0.0020 |
| 104 |
Carbamoyl Phosphate Synthetase 1 Activator [EPC] |
1 |
0.0020 |
| 105 |
beta-Adrenergic Blocker [EPC] |
528 |
0.0020 |
| 106 |
Vitamin C [EPC] |
532 |
0.0020 |
| 107 |
Vitamin B12 [EPC] |
535 |
0.0020 |
| 108 |
Fluoroquinolone Antibacterial [EPC] |
202 |
0.0020 |
| 109 |
Antimycobacterial [EPC] |
30 |
0.0020 |
| 110 |
Antiparasitic [EPC] |
9 |
0.0020 |
| 111 |
Vitamin D [EPC] |
489 |
0.0020 |
| 112 |
Prostaglandin E1 Analog [EPC] |
29 |
0.0019 |
| 113 |
Pediculicide [EPC] |
9 |
0.0019 |
| 114 |
Sulfone [EPC] |
15 |
0.0019 |
| 115 |
Phenothiazine [EPC] |
41 |
0.0018 |
| 116 |
Amide Local Anesthetic [EPC] |
112 |
0.0018 |
| 117 |
Thiazide Diuretic [EPC] |
337 |
0.0018 |
| 118 |
Aluminum Complex [EPC] |
34 |
0.0018 |
| 119 |
Dihydropyridine Calcium Channel Blocker [EPC] |
453 |
0.0018 |
| 120 |
Calcitonin [EPC] |
5 |
0.0018 |
| 121 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
131 |
0.0017 |
| 122 |
Oxytocic [EPC] |
4 |
0.0017 |
| 123 |
Interleukin-17 Receptor A Antagonist [EPC] |
2 |
0.0017 |
| 124 |
Provitamin D2 Compound [EPC] |
502 |
0.0017 |
| 125 |
Aldosterone Antagonist [EPC] |
196 |
0.0017 |
| 126 |
Nitrofuran Antibacterial [EPC] |
33 |
0.0016 |
| 127 |
Sulfonylurea [EPC] |
211 |
0.0016 |
| 128 |
Calcitonin Gene-related Peptide Antagonist [EPC] |
4 |
0.0016 |
| 129 |
Tetracycline-class Drug [EPC] |
77 |
0.0016 |
| 130 |
Nitroimidazole Antimicrobial [EPC] |
87 |
0.0016 |
| 131 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
75 |
0.0016 |
| 132 |
Glycopeptide Antibacterial [EPC] |
77 |
0.0016 |
| 133 |
Loop Diuretic [EPC] |
572 |
0.0016 |
| 134 |
Bile Acid [EPC] |
23 |
0.0016 |
| 135 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
76 |
0.0016 |
| 136 |
Azole Antifungal [EPC] |
186 |
0.0016 |
| 137 |
Phosphodiesterase 3 Inhibitor [EPC] |
8 |
0.0016 |
| 138 |
Blood Viscosity Reducer [EPC] |
5 |
0.0016 |
| 139 |
Interferon gamma [EPC] |
2 |
0.0015 |
| 140 |
Antiarrhythmic [EPC] |
114 |
0.0015 |
| 141 |
beta3-Adrenergic Agonist [EPC] |
43 |
0.0015 |
| 142 |
alpha-Hydroxy Acid [EPC] |
2 |
0.0015 |
| 143 |
Estrogen [EPC] |
239 |
0.0015 |
| 144 |
Folate Analog [EPC] |
1 |
0.0015 |
| 145 |
CCR5 Co-receptor Antagonist [EPC] |
3 |
0.0015 |
| 146 |
Opioid Antagonist [EPC] |
1 |
0.0015 |
| 147 |
Xanthine Oxidase Inhibitor [EPC] |
201 |
0.0014 |
| 148 |
Lincosamide Antibacterial [EPC] |
35 |
0.0014 |
| 149 |
alpha-Adrenergic Blocker [EPC] |
166 |
0.0014 |
| 150 |
Corticosteroid [EPC] |
1382 |
0.0014 |
| 151 |
Retinoid [EPC] |
317 |
0.0014 |
| 152 |
Pleuromutilin Antibacterial [EPC] |
1 |
0.0014 |
| 153 |
Chloride Channel Activator [EPC] |
11 |
0.0014 |
| 154 |
Progesterone [EPC] |
22 |
0.0014 |
| 155 |
Thiazide-like Diuretic [EPC] |
46 |
0.0014 |
| 156 |
Non-narcotic Antitussive [EPC] |
16 |
0.0014 |
| 157 |
Parenteral Iron Replacement [EPC] |
14 |
0.0014 |
| 158 |
Progestin Antagonist [EPC] |
5 |
0.0014 |
| 159 |
Protease Inhibitor [EPC] |
56 |
0.0014 |
| 160 |
Progestin [EPC] |
331 |
0.0013 |
| 161 |
Bismuth [EPC] |
6 |
0.0013 |
| 162 |
Plasma Kallikrein Inhibitor [EPC] |
4 |
0.0013 |
| 163 |
Angiotensin 2 Receptor Blocker [EPC] |
362 |
0.0013 |
| 164 |
Quinolone Antimicrobial [EPC] |
10 |
0.0013 |
| 165 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
112 |
0.0013 |
| 166 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
114 |
0.0013 |
| 167 |
Sulfonamide Antibacterial [EPC] |
4 |
0.0013 |
| 168 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
64 |
0.0013 |
| 169 |
Potassium-sparing Diuretic [EPC] |
21 |
0.0013 |
| 170 |
Serotonin-3 Receptor Antagonist [EPC] |
114 |
0.0013 |
| 171 |
Insulin [EPC] |
59 |
0.0013 |
| 172 |
Catecholamine [EPC] |
69 |
0.0012 |
| 173 |
alpha-Adrenergic Agonist [EPC] |
60 |
0.0012 |
| 174 |
Calcium [EPC] |
148 |
0.0012 |
| 175 |
Polyene Antifungal [EPC] |
42 |
0.0012 |
| 176 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
137 |
0.0012 |
| 177 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
7 |
0.0012 |
| 178 |
Insulin Analog [EPC] |
440 |
0.0012 |
| 179 |
Cytochrome P450 3A Inhibitor [EPC] |
64 |
0.0012 |
| 180 |
Interleukin-5 Antagonist [EPC] |
32 |
0.0011 |
| 181 |
Prostaglandin Analog [EPC] |
89 |
0.0011 |
| 182 |
Anti-IgE [EPC] |
62 |
0.0011 |
| 183 |
Lipid-based Polyene Antifungal [EPC] |
15 |
0.0011 |
| 184 |
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] |
8 |
0.0011 |
| 185 |
Melanin Synthesis Inhibitor [EPC] |
1 |
0.0011 |
| 186 |
Vitamin K [EPC] |
7 |
0.0011 |
| 187 |
Lipid Emulsion [EPC] |
2 |
0.0011 |
| 188 |
Histamine-2 Receptor Antagonist [EPC] |
303 |
0.0011 |
| 189 |
Uric Acid-specific Enzyme [EPC] |
2 |
0.0011 |
| 190 |
Phosphodiesterase 5 Inhibitor [EPC] |
109 |
0.0010 |
| 191 |
Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] |
1 |
0.0010 |
| 192 |
Adenosine Receptor Agonist [EPC] |
6 |
0.0010 |
| 193 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
1 |
0.0010 |
| 194 |
Intestinal Lipase Inhibitor [EPC] |
24 |
0.0010 |
| 195 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
6 |
0.0010 |
| 196 |
Interferon beta [EPC] |
189 |
0.0010 |
| 197 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
18 |
0.0010 |
| 198 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
41 |
0.0009 |
| 199 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
8 |
0.0009 |
| 200 |
Anti-coagulant [EPC] |
5 |
0.0009 |
| 201 |
Alkaloid [EPC] |
19 |
0.0009 |
| 202 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
13 |
0.0009 |
| 203 |
Androgen Receptor Inhibitor [EPC] |
53 |
0.0008 |
| 204 |
Arteriolar Vasodilator [EPC] |
24 |
0.0008 |
| 205 |
Human Immunoglobulin G [EPC] |
6 |
0.0008 |
| 206 |
Vitamin D3 Analog [EPC] |
12 |
0.0008 |
| 207 |
Aromatase Inhibitor [EPC] |
63 |
0.0007 |
| 208 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
11 |
0.0007 |
| 209 |
Radioactive Diagnostic Agent [EPC] |
1 |
0.0007 |
| 210 |
CD52-directed Cytolytic Antibody [EPC] |
12 |
0.0007 |
| 211 |
Paramagnetic Contrast Agent [EPC] |
3 |
0.0007 |
| 212 |
P2Y12 Platelet Inhibitor [EPC] |
18 |
0.0007 |
| 213 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
60 |
0.0007 |
| 214 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
11 |
0.0007 |
| 215 |
Rifamycin Antibacterial [EPC] |
16 |
0.0007 |
| 216 |
Purine Antimetabolite [EPC] |
50 |
0.0007 |
| 217 |
Iron Chelator [EPC] |
18 |
0.0007 |
| 218 |
Bile Acid Sequestrant [EPC] |
6 |
0.0007 |
| 219 |
Vitamin D2 Analog [EPC] |
10 |
0.0007 |
| 220 |
Anti-anginal [EPC] |
11 |
0.0006 |
| 221 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
25 |
0.0006 |
| 222 |
Aminoglycoside Antibacterial [EPC] |
21 |
0.0006 |
| 223 |
Radiographic Contrast Agent [EPC] |
11 |
0.0006 |
| 224 |
Nuclear Export Inhibitor [EPC] |
3 |
0.0006 |
| 225 |
Folate Analog Metabolic Inhibitor [EPC] |
205 |
0.0006 |
| 226 |
Antiseptic [EPC] |
2 |
0.0006 |
| 227 |
Prostacyclin Receptor Agonist [EPC] |
11 |
0.0006 |
| 228 |
Antisense Oligonucleotide [EPC] |
4 |
0.0006 |
| 229 |
Pyrimidine Synthesis Inhibitor [EPC] |
23 |
0.0006 |
| 230 |
Antimetabolite Immunosuppressant [EPC] |
6 |
0.0005 |
| 231 |
Guanylate Cyclase-C Agonist [EPC] |
11 |
0.0005 |
| 232 |
Potassium Channel Blocker [EPC] |
37 |
0.0005 |
| 233 |
Integrin Receptor Antagonist [EPC] |
118 |
0.0005 |
| 234 |
Kinase Inhibitor [EPC] |
227 |
0.0005 |
| 235 |
CD20-directed Cytolytic Antibody [EPC] |
110 |
0.0005 |
| 236 |
CD38-directed Cytolytic Antibody [EPC] |
14 |
0.0005 |
| 237 |
Asparagine-specific Enzyme [EPC] |
5 |
0.0005 |
| 238 |
Factor Xa Inhibitor [EPC] |
181 |
0.0005 |
| 239 |
CD30-directed Immunoconjugate [EPC] |
3 |
0.0005 |
| 240 |
Vitamin D Analog [EPC] |
8 |
0.0004 |
| 241 |
Copper-containing Intrauterine Device [EPC] |
16 |
0.0004 |
| 242 |
Glinide [EPC] |
3 |
0.0004 |
| 243 |
GLP-2 Analog [EPC] |
4 |
0.0004 |
| 244 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
1 |
0.0004 |
| 245 |
Potassium Binder [EPC] |
6 |
0.0004 |
| 246 |
Phenylalanine Metabolizing Enzyme [EPC] |
2 |
0.0004 |
| 247 |
Platinum-based Drug [EPC] |
81 |
0.0004 |
| 248 |
Calcitonin Gene-related Peptide Receptor Antagonist [EPC] |
2 |
0.0004 |
| 249 |
Contrast Agent for Ultrasound Imaging [EPC] |
2 |
0.0004 |
| 250 |
Rifamycin Antimycobacterial [EPC] |
1 |
0.0004 |
| 251 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
2 |
0.0004 |
| 252 |
Alkylating Drug [EPC] |
75 |
0.0004 |
| 253 |
mu-Opioid Receptor Agonist [EPC] |
1 |
0.0004 |
| 254 |
Aminosalicylate [EPC] |
39 |
0.0004 |
| 255 |
Complement Inhibitor [EPC] |
17 |
0.0004 |
| 256 |
Interleukin-2 Receptor Blocking Antibody [EPC] |
3 |
0.0004 |
| 257 |
Farnesoid X Receptor Agonist [EPC] |
2 |
0.0003 |
| 258 |
Topoisomerase Inhibitor [EPC] |
18 |
0.0003 |
| 259 |
Phosphodiesterase 4 Inhibitor [EPC] |
46 |
0.0003 |
| 260 |
Janus Kinase Inhibitor [EPC] |
17 |
0.0003 |
| 261 |
GLP-1 Receptor Agonist [EPC] |
66 |
0.0003 |
| 262 |
Antirheumatic Agent [EPC] |
27 |
0.0003 |
| 263 |
Prostacycline [EPC] |
3 |
0.0003 |
| 264 |
Erythropoiesis-stimulating Agent [EPC] |
20 |
0.0003 |
| 265 |
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] |
4 |
0.0003 |
| 266 |
Parathyroid Hormone Analog [EPC] |
32 |
0.0003 |
| 267 |
Nucleoside Metabolic Inhibitor [EPC] |
64 |
0.0003 |
| 268 |
Acetylcholine Release Inhibitor [EPC] |
20 |
0.0003 |
| 269 |
Tumor Necrosis Factor Blocker [EPC] |
226 |
0.0003 |
| 270 |
Prostacycline Vasodilator [EPC] |
27 |
0.0003 |
| 271 |
alpha-Glucosidase Inhibitor [EPC] |
1 |
0.0003 |
| 272 |
Gadolinium-based Contrast Agent [EPC] |
1 |
0.0003 |
| 273 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
10 |
0.0003 |
| 274 |
Selective T Cell Costimulation Modulator [EPC] |
27 |
0.0003 |
| 275 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
7 |
0.0003 |
| 276 |
Soluble Guanylate Cyclase Stimulator [EPC] |
6 |
0.0002 |
| 277 |
Proteasome Inhibitor [EPC] |
22 |
0.0002 |
| 278 |
Interleukin-1 Receptor Antagonist [EPC] |
3 |
0.0002 |
| 279 |
Thalidomide Analog [EPC] |
97 |
0.0002 |
| 280 |
Interleukin-12 Antagonist [EPC] |
18 |
0.0002 |
| 281 |
Pyridone [EPC] |
8 |
0.0002 |
| 282 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
33 |
0.0002 |
| 283 |
Endothelin Receptor Antagonist [EPC] |
38 |
0.0002 |
| 284 |
Parathyroid Hormone [EPC] |
1 |
0.0002 |
| 285 |
Vasopressin V2 Receptor Antagonist [EPC] |
2 |
0.0002 |
| 286 |
SLAMF7-directed Immunostimulatory Antibody [EPC] |
1 |
0.0002 |
| 287 |
Somatostatin Analog [EPC] |
1 |
0.0002 |
| 288 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
31 |
0.0002 |
| 289 |
Microtubule Inhibitor [EPC] |
25 |
0.0002 |
| 290 |
CTLA-4-directed Blocking Antibody [EPC] |
7 |
0.0002 |
| 291 |
RANK Ligand Inhibitor [EPC] |
35 |
0.0002 |
| 292 |
Interleukin-6 Receptor Antagonist [EPC] |
19 |
0.0002 |
| 293 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3 |
0.0002 |
| 294 |
BCL-2 Inhibitor [EPC] |
7 |
0.0002 |
| 295 |
Interleukin-17A Antagonist [EPC] |
28 |
0.0002 |
| 296 |
Interleukin-23 Antagonist [EPC] |
22 |
0.0002 |
| 297 |
Echinocandin Antifungal [EPC] |
1 |
0.0002 |
| 298 |
Estrogen Receptor Antagonist [EPC] |
4 |
0.0002 |
| 299 |
Leukocyte Growth Factor [EPC] |
19 |
0.0002 |
| 300 |
Thrombopoietin Receptor Agonist [EPC] |
2 |
0.0002 |
| 301 |
PCSK9 Inhibitor [EPC] |
17 |
0.0001 |
| 302 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
21 |
0.0001 |
| 303 |
Hedgehog Pathway Inhibitor [EPC] |
1 |
0.0001 |
| 304 |
HER2/neu Receptor Antagonist [EPC] |
6 |
0.0001 |
| 305 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
1 |
0.0001 |
| 306 |
Lipopeptide Antibacterial [EPC] |
1 |
0.0001 |
| 307 |
Parathyroid Hormone-Related Peptide Analog [EPC] |
1 |
0.0001 |